Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 3, 2007, Pages 284-291

  Shimura, Masahiko ^a   Nakazawa, Toru ^b   Yasuda, Kanako ^a   Nishida, Kohji ^b  

^a NTT East Tohoku Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DICLOD; DICLOFENAC; GATIFLOXACIN; RINDELON; UNCLASSIFIED DRUG;

AGED; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MEASUREMENT; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETAMETHASONE; CATARACT; CATARACT EXTRACTION; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DICLOFENAC; FEMALE; FOVEA CENTRALIS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 34250845503     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.134     Document Type: Article

References (34)

1. Flach, A.J. The incidence, pathogenesis, and treatment of cystoid macular edema following cataract surgery. Trans. Am. Ophthalmol. Soc. 96:557-634, 1998.
2. Miyake, K., Ota, I., Ibaraki, N., et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch. Ophthalmol. 119:387-394, 2001.
3. Miyake, K., Masuda, K., Shirato, S., et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: A multicentered, prospective trial. Jpn. J. Ophthalmol. 44:58-67, 2000.
4. Cunha-Vaz, J., and Bernardes, R. Nonproliferative retinopathy in diabetes type 2: Initial stages and characterization of phenotypes. Prog. Retin. Eye Res. 24:355-377, 2005.
5. Krepler, K., Biowski, R., Schrey, S., et al. Cataract surgery in patients with diabetic retinopathy: Visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefe's Arch. Clin. Exp. Ophthalmol. 240:735-738, 2002.
6. Rowen, S. Preoperative and postoperative medications used for cataract surgery. Curr. Opin. Ophthalmol. 10:29-35, 1999.
7. Nelson, M.L., and Martidis, A. Managing cystoid macular edema after cataract surgery. Curr. Opin. Ophthalmol. 14:39-43, 2003.
8. The Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J. Catarct Refract. Surg. 23:1183-1189, 1997.
9. Solomon, L.D. Efficacy of flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema: The Flurbiprofen-CME Study Group. J. Cataract Refract. Surg. 21:73-81, 1995.
10. Rossetti, L., Bujtar, E., Castoldi, D., et al. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. J. Cataract Refract. Surg. 22:794-799, 1996.
11. Goa, K.L., and Chrisp, P. Ocular diclofenac: A review of its pharmacology and clinical use in cataract surgery, and potential in other inflammatory ocular conditions. Drugs Aging 2:473-486, 1992.
12. Araie, M., Sawa, M., and Takase, M. Topical flurbiprofen and diclofenac suppress blood-aqueous barrier breakdown in cataract surgery. Jpn. J. Ophthalmol. 27:535-542, 1983.
13. Flach, A.J., Kraff, M.C., Sanders, D.R., et al. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood aqueous barrier. Arch. Ophthalmol. 106:480-483, 1988.
14. Othenin-Girard, P., Tritten, J.J., Pittet, N., et al. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. J. Cataract Refract. Surg. 20:9-12, 1994.
15. Patel, J.I., Hykin, P.G., and Cree, I.A. Diabetic cataract removal: Postoperative progression of maculopathy-growth factor and clinical analysis. Br. J. Ophthalmol. 90:697-701, 2006.
16. Degenring, R.F., Vey, S., Kamppeter, B., et al. Effect of uncomplicated phacoemulsification on the central retina in diabetic and nondiabetic subjects. Graefe's Arch. Clin. Exp. Ophthalmol. In press, 2006.
17. Rivellese, M., George, A., Sulkes, D., et al. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg. Lasers 31:192-197, 2000.
18. Massin, P., Vicaut, E., Haouchine, B., et al. Reproducibility of retinal mapping using optical coherence tomography. Arch. Ophthalmol. 119:1135-1142, 2001.
19. Miyake, K. Prevention of cystoid macular edema after lens extraction by topical indomethacin. II. A control study in bilateral extractions. Jpn. J. Ophthalmol. 22:80-94, 1978.
20. Lobo, C.L., Bernardes, R.C., and Cunha-Vaz, J.G. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch. Ophthalmol. 118:1364-1369, 2000.
21. Funatsu, H., Yamashita, H., Ikeda, T., et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110:1690-1696, 2003.
22. Funatsu, H., Yamashita, H., Sakata, K., et al. Vitreous levels of vascular endothelial growth factor and intracellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 112:806-816, 2005.
23. Petel, J.I., Saleh, G.M., Hykin, P.G., et al. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye Epub ahead of print, 2006.
24. Miyake, K. Indomethacin in the treatment of postoperative cystoid macular edema. Surv. Ophthalmol. 28:554-568, 1984.
25. Wright, M., Butt, Z., McIlwaine, G., et al. Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Br. J. Ophthalmol. 81: 299-301, 1997.
26. Suharwardy, J., Ling, C., Bell, J.A., et al. A comparative trial between diclofenac-gentamicin and betamethasone-neomycin drops in patients undergoing cataract extraction. Eye 8:550-554, 1994.
27. Roberts, C.W., and Brennan, K.M. A comparison of topical diclofenac with predonisolone for postcataract inflammation. Arch. Ophthalmol. 113:725-727, 1995.
28. Findl, O., Amon, M., Petternel, V., et al. Early objective assessment of intraocular inflammation after phacoemulsification cataract surgery. J. Cataract Refract. Surg. 29:2143-2147, 2003.
29. Malecaze, F., Chollet, P., Cavrois, E., et al. Role of interleukin-6 in the inflammatory response after cataract surgery. Arch. Ophthalmol. 109:1681-1683, 1991.
30. Romeo-Aroca, P., Fernandez-Ballart, J., Almena-Garcia, M., et al. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J. Cataract Refract. Surg. 32:1438-1444, 2006.
31. Sokol, S., Moskowitz, A., Skarf, B., et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch. Ophthalmol. 103:51-54, 1985.
32. Issa, S.A., Pacheco, J., Mahmood, U., et al. A novel index for predicting intraocular pressure reduction following cataract surgery. Br. J. Ophthalmol. 89:543-546, 2005.
33. Shimura, M., Yasuda, K., and Shiono, T. Posterior subtenon injection of triamcinolone acetonide prevents pan-retinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision. Ophthalmology 113:381-387, 2006.
34. Massin, P., Andren, F., Haouchine, B., et al. Intravitreal triamcinolone acetonide for diabetic macular edema - preliminary results of a prospective controlled trial. Ophthalmology 111:218-225, 2004.